Trial Profile
Propylactic Use of Entecavir for Biological Agents Associated Hepatitis B Virus Reactivation in Inflammatory Arthritis Patients: a Randomized Controlled Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2021
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 11 Mar 2019 Planned End Date changed from 1 Dec 2018 to 31 Dec 2019.
- 11 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 31 Mar 2016 Planned End Date changed from 1 Jul 2016 to 1 Dec 2018 as per ClinicalTrials.gov record.